ArticleThe oncologist2026

Gastric and rectal administration of encorafenib with targeted chemotherapy against BRAF V600E-mutant rectal cancer with bowel obstruction.

Maximilian Alexander Funk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.